Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126632992 | 12663299 | 2 | F | 2013 | 20160915 | 20160818 | 20160919 | EXP | PHFR2016GB006346 | NOVARTIS | 20.00 | YR | M | Y | 0.00000 | 20160919 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126632992 | 12663299 | 1 | PS | TEGRETOL | CARBAMAZEPINE | 1 | Oral | 1500 MG, BID (WORKING TOWARDS 1600 MG) | U | H5644, H5639 | 18927 | 1500 | MG | SYRUP | BID | ||||
| 126632992 | 12663299 | 2 | SS | TEGRETOL | CARBAMAZEPINE | 1 | Rectal | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126632992 | 12663299 | 1 | Epilepsy |
| 126632992 | 12663299 | 2 | Epilepsy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126632992 | 12663299 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126632992 | 12663299 | Feeling abnormal | |
| 126632992 | 12663299 | Nausea | |
| 126632992 | 12663299 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126632992 | 12663299 | 1 | 2013 | 0 |